Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Nutr Food Res ; 68(9): e2300759, 2024 May.
Article in English | MEDLINE | ID: mdl-38651284

ABSTRACT

SCOPE: Tolypocladium sinense is a fungus isolated from Cordyceps. Cordyceps has some medicinal value and is also a daily health care product. This study explores the preventive effects of T. sinense mycelium polysaccharide (TSMP) on high-fat diet-induced obesity and chronic inflammation in mice. METHODS AND RESULTS: Here, the study establishes an obese mouse model induced by high-fat diet. In this study, the mice are administered TSMP daily basis to evaluate its effect on alleviating obesity. The results show that TSMP can significantly inhibit obesity and alleviate dyslipidemia by regulating the expression of lipid metabolism-related genes such as liver kinase B1 (LKB1), phosphorylated AMP-activated protein kinase (pAMPK), peroxisome proliferator activated receptor α (PPARα), fatty acid synthase (FAS), and hydroxymethylglutaryl-CoA reductase (HMGCR) in the liver. TSMP can increase the protein expression of zona occludens-1 (ZO-1), Occludin, and Claudin-1 in the colon, improve the intestinal barrier dysfunction, and reduce the level of serum LPS, thereby reducing the inflammatory response. 16S rDNA sequencing shows that TSMP alters the intestinal microbiota by increasing the relative abundance of Akkermansia, Lactobacillus, and Prevotellaceae_NK3B31_group, while decreasing the relative abundance of Faecalibaculum. CONCLUSION: The findings show that TSMP can inhibit obesity and alleviates obesity-related lipid metabolism disorders, inflammatory responses, and oxidative stress by modulating the gut microbiota and improving intestinal barrier.


Subject(s)
Diet, High-Fat , Gastrointestinal Microbiome , Inflammation , Mice, Inbred C57BL , Mycelium , Obesity , Diet, High-Fat/adverse effects , Animals , Gastrointestinal Microbiome/drug effects , Obesity/drug therapy , Male , Mycelium/chemistry , Inflammation/drug therapy , Lipid Metabolism Disorders/drug therapy , Mice , Lipid Metabolism/drug effects , Polysaccharides/pharmacology , Hypocreales , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Fungal Polysaccharides/pharmacology , Liver/drug effects , Liver/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...